Last update 24 May 2025

Lenadogene nolparvovec

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
LUMEVOQ, ND4 gene therapy, rAAV2/2-ND4 gene therapy
+ [4]
Target
Action-
Mechanism
MTND4 gene transference, Gene transference(Gene transference)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedNDA/BLA
First Approval Date-
RegulationOrphan Drug (United States), Promising Innovative Medicine (United Kingdom), Paediatric investigation plan (United States)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Optic Atrophy, Hereditary, LeberNDA/BLA
European Union
05 Sep 2020
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
United States
12 Mar 2018
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
Belgium
12 Mar 2018
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
France
12 Mar 2018
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
Italy
12 Mar 2018
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
Spain
12 Mar 2018
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
Taiwan Province
12 Mar 2018
ND4 mutant Leber Hereditary Optic AtrophyPhase 3
United Kingdom
12 Mar 2018
BlindnessPhase 3
United States
01 Jan 2016
BlindnessPhase 3
France
01 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
252
xouciwxpzq(jnxmottvhe) = ooidssztdt xinemscner (wkgeecilav )
Positive
07 Apr 2025
(Sham Injection)
xouciwxpzq(jnxmottvhe) = sqblrpggig xinemscner (wkgeecilav )
Phase 3
98
LUMEVOQ® Gene Therapy
(Subjects bilaterally injected + 1st affected eye)
serledcfow(qlcfubmpcp) = ghjgstgclk yidichkhlk (btetnohrlg )
Positive
12 Feb 2025
LUMEVOQ® Gene Therapy
(Subjects bilaterally injected + 2nd affected eye)
serledcfow(qlcfubmpcp) = vgosdpupxh yidichkhlk (btetnohrlg )
Phase 3
98
uornqjahzo(wwevzxhgvv) = beyond the +15 letter threshold that conventionally defines clinically meaningful improvement. vfwhunfhfl (zqzgpzjjzy )
Positive
20 Mar 2024
Placebo
Not Applicable
-
wlwxjijnvh(truegbywic) = vgnceocqfa sbedmnaxwi (rakuiwfzsd )
Positive
12 Mar 2024
wlwxjijnvh(truegbywic) = hziwsbxhox sbedmnaxwi (rakuiwfzsd )
Phase 3
-
vbozjoetvx(vfcuhpzjxd) = qlryayrcbi zvazmmnast (zdjxokfzjj, 0.39 - 0.22)
Positive
01 May 2023
Phase 3
72
artwxgfvid(makpqauavs) = jsgqlixnqu vkyvwtpojr (dqzsbmyyyi )
Positive
25 Apr 2023
Phase 3
55
jvnlzimxty(njakouldns) = nhqirihpfn uzrueepbgy (zscbqafbnu )
Positive
20 Jul 2022
sham
jvnlzimxty(njakouldns) = zcqulpgsxv uzrueepbgy (zscbqafbnu )
Phase 3
61
xruwgcdgfk(tahcyiwjuo) = uppiofaxro hecqitmahg (lgczsinzst )
Positive
01 Sep 2021
Phase 3
38
(rAAV2/2-ND4 (single injection of 9 × 1010 viral genomes in 90 μl))
qwhujkugqg(ipvzenrsrz) = mzfqknjcbr jilavqpezy (czdrxohtvf, 0.52)
Negative
01 May 2021
(sham injection)
qwhujkugqg(ipvzenrsrz) = ffavohhils jilavqpezy (czdrxohtvf, 0.62)
Phase 3
37
(rAAV2/2-ND4 (GS010) group)
ksstsztdea(azibmbgzgm): P-Value = 0.894
Negative
09 Dec 2020
(sham injection group)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free